Verified peer comparison
Advanced Flower Capital Inc. - Common Stock vs DiaMedica Therapeutics Financial Comparison
Advanced Flower Capital Inc. - Common Stock versus DiaMedica Therapeutics using…
Direct answer
Advanced Flower Capital Inc. - Common Stock and DiaMedica Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Verified data
- Advanced Flower Capital Inc. - Common Stock Revenue
- 31,322,137 USD
- DiaMedica Therapeutics Revenue
- 0 USD
- Advanced Flower Capital Inc. - Common Stock Operating income
- -13,653,520 USD
- DiaMedica Therapeutics Operating income
- -34,397,000 USD